Relay Therapeutics shares rise 2.19% premarket after former CLO Brian Adams appointed as Kymera Therapeutics' Chief Legal Officer.

jueves, 4 de septiembre de 2025, 8:14 am ET1 min de lectura
RLAY--
Relay Therapeutics, Inc. rose 2.19% in premarket trading, following the news that its former Chief Legal Officer, Brian Adams, has been appointed as the new Chief Legal Officer and Corporate Secretary of Kymera Therapeutics, Inc. This move suggests that Relay Therapeutics is in a strong position to continue its growth and success in the life sciences industry.

Relay Therapeutics shares rise 2.19% premarket after former CLO Brian Adams appointed as Kymera Therapeutics' Chief Legal Officer.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios